of SARS-CoV-2 over the last year, which are exemplified by the licensing of several vaccines (in the UK those made by Pfizer-BioNtech, Moderna, and Oxford-AstraZeneca), which are being rolled out in massive global vaccination programs, with the aim to reach billions of individuals in 2021...